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SUMMARY
Treponema denticola, a periopathogen, evades
complement-mediated killing by binding the nega-
tive complement regulatory protein factor H (FH)
to its surface via the FhbB protein. Paradoxically,
bound FH is cleaved by T. denticola’s dentilisin
protease, a process hypothesized to trigger local-
ized dysregulation of complement activation in
periodontal pockets. The ability of other oral
treponemes to evade complement-mediated killing
and bind and cleave FH has not been assessed.
In this report, we demonstrate that representative
isolates of Treponema socranskii, Treponema
medium, Treponema pectinovorum and Trepo-
nema maltophilum are also serum resistant,
whereas Treponema vincentii and Treponema
amylovorum are serum sensitive. Although
T. denticola’s ability to evade complement-medi-
ated killing is strictly dependent on FH binding,
other serum-resistant treponemal species lack
FhbB and do not bind FH, indicating an FH-inde-
pendent mechanism of complement evasion. To
assess the inﬂuence of FhbB sequence variation
on FH binding and cleavage by T. denticola, fhbB
sequences were determined for 30 isolates. Three
distinct phyletic types were identiﬁed. All T. denti-
cola strains bound FH and were serum resistant,
but differences in binding kinetics, dentilisin
activity and FH cleavage ability were observed.
Based on these analyses, we hypothesize that the
composition of the T. denticola population is a
determining factor that inﬂuences the progression
and severity of periodontal disease.
INTRODUCTION
Periodontitis is a chronic inﬂammatory disease initi-
ated by a complex microbial bioﬁlm that results in
destruction of the periodontium, culminating in alveo-
lar bone resorption and edentulism (Darveau, 2010).
Distinct bacterial consortia have been identiﬁed that
correlate with either healthy or diseased tissue.
Elevated numbers of bacteria in the ‘red-complex’
(Porphyromonas gingivalis, Tannerella forsythia and
Treponema denticola) correlate strongly with peri-
odontal disease progression and severity (Socransky
et al., 1998). Oral treponemes, including T. denticola,
are anaerobic spirochetes that are found at the
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interface between the subgingival plaque and the
periodontal epithelium (Ellen & Galimanas, 2005).
Treponema denticola is a minor component of the
bacterial population in the healthy subgingiva but may
exceed 40% of the total bacterial population in dis-
eased periodontal pockets (Ellen & Galimanas,
2005).
The subgingival crevice is bathed in crevicular ﬂuid
that is rich in serum proteins, antimicrobial peptides
and active complement (Schenkein & Genco, 1977b;
Boackle et al., 1978; Boackle, 1991). Complement is
a key part of the innate immune system (Ricklin
et al., 2010). Host cells are protected from activated
complement by membrane-bound and ﬂuid-phase
complement regulators including factor H (FH). FH is
a 155-kDa glycoprotein that consists of 20 comple-
ment control protein (CCP) domains and binds to host
cell glycosaminoglycans via CCPs 6–7 and 19–20
(Ferreira et al., 2010). Although FH is a key regulator
of the alternative complement pathway, its ability to
inﬂuence several immunological pathways and pro-
cesses that are relevant to periodontal disease is
now clear (Mihlan et al., 2009; Zipfel & Skerka, 2009;
Ferreira et al., 2010; Barthel et al., 2012).
Treponema denticola strain 35405 exploits the neg-
ative complement regulatory activity of FH by binding
it to an 11.4-kDa surface exposed lipoprotein desig-
nated as FhbB (McDowell et al., 2005, 2007). The
binding interaction occurs between the negatively
charged face of FhbB and the CCP 7 domain of FH
(McDowell et al., 2005, 2007; Miller et al., 2011,
2012). Using a T. denticola 35405 fhbB deletion
mutant (35405δfhbB), it was demonstrated that serum
resistance is strictly dependent on this interaction
(McDowell et al., 2011). Paradoxically, FH bound to
the T. denticola surface is cleaved by the protease
dentilisin (McDowell et al., 2009). It has been hypoth-
esized that as the T. denticola population expands
with disease progression, cleavage of FH by dentili-
sin leads to local dysregulation of complement activa-
tion initiating a cascade of destructive downstream
events that result in tissue destruction and bone
resorption (Miller et al., 2012). This in turn creates a
favorable environment for the survival of other perio-
pathogens.
In this study, we assessed the complement sensi-
tivity of six oral treponeme species in addition to a
comprehensive panel of T. denticola strains. All
T. denticola strains were determined to be serum
resistant and to bind FH. However, other species that
were serum resistant did not produce FhbB or bind
FH, indicating that they employ alternative methods
for complement evasion. Since FhbB and FH binding
has, to date, been assessed in only four T. denticola
strains (35405, 33520, 33521 and GM1), in this study
we determined fhbB sequences and assessed FH
binding, dentilisin activity and FH cleavage for a large
panel of T. denticola isolates (McDowell et al., 2005,
2007). The inﬂuence of fhbB sequence variation on
FH binding and serum resistance was also assessed
and the kinetics of the FhbB–FH interaction was
determined for representative recombinant FhbB
proteins using surface plasmon resonance. This study
provides a comprehensive analysis of the serum
resistance of oral treponemes. The results demon-
strate that some oral treponemes employ an
FH-independent mechanism to evade complement-
mediated destruction. In addition, the data indicate
signiﬁcant phenotypic variation among T. denticola
isolates. This observation is of epidemiological and
pathogenic relevance because it suggests that the
composition of the T. denticola population may inﬂu-
ence the progression and severity of disease.
METHODS
Bacterial strains and generation of recombinant
proteins
Treponema medium (ATCC 700293), Treponema
socranskii (ATCC 35535), Treponema vincentii
(ATCC 35580) and all strains of T. denticola were
grown in new oral spirochete media under anaerobic
conditions as previously described (McDowell et al.,
2005). Treponema amylovorum (ATCC 700288),
Treponema maltophilum (ATCC 51939) and Trepo-
nema pectinovorum (ATCC 33768) were grown in
OMIZ-P4 under anaerobic conditions. Recombinant
(r-) FhbB proteins were generated, as previously
described, using primers designed to amplify the
mature protein (removing the 23 amino acid signal
peptide) with sequences that allow for ligase-indepen-
dent cloning with the pET46 Ek/LIC vector (Table 1)
(Miller et al., 2012). Recombinant FH proteins con-
sisting of different CCP domains and r-FhbA, an FH-
binding protein from Borrelia hermsii, were generated
in earlier studies (Hovis et al., 2008; Miller et al.,
2013).
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DNA sequencing, phylogenetic and structural
analyses
The fhbB gene was ampliﬁed using polymerase chain
reaction and sequenced from 30 T. denticola strains
as previously described (McDowell et al., 2007). The
primers used for the polymerase chain reaction are
listed in Table 1. Additional sequences, generated as
part of the Human Microbiome U54 initiative (broadin-
stitute.org) derived from T. denticola isolates AL-2,
F0402, H-22, H-1, MYR, US-Trep1, SP23, SP32,
SP33, SP37 and SP34 were also analysed. FhbB
sequences were aligned using CLUSTALOMEGA (Sievers
et al., 2011) and phylogenetic analyses conducted
using MEGA5 (Tamura et al., 2011). Phylogenetic trees
were constructed using the neighbor-joining method
and the standard errors of distances were computed
by bootstrap analysis using 500 replications. The
sequences determined as part of this study were
assigned GenBank accession numbers HM991217–
HM991226. The structural relationships among FhbB
variants were assessed using computer-assisted
structural modeling. A structural model of different
FhbB types was created using the known structure of
FhbB35405 (pdb code 3R15) (Miller et al., 2011,
2012). Brieﬂy, CLUSTALW2 (Larkin et al., 2007) was
used to align the FhbB sequences (residues 24–101).
Structural models were generated and compared with
the FhbB35405 structure using MODELER9v1 (Sali, 1995;
Sali et al., 1995). MOLPROBITY (version 3.15) (Davis
et al., 2004) was used to assess all-atom contacts
and geometry. CONSURF was used to map the location
of conserved and divergent residues using the
FhbB35405 as the reference structure (Ashkenazy
et al., 2010).
Analyses of the FhbB–FH interaction using
afﬁnity ligand-binding immunoblot assays,
sucrose octasulfate competitive binding analyses,
enzyme-linked immunosorbent assays, and
surface plasmon resonance
FH afﬁnity ligand-binding immunoblot (ALBI) assays
(a membrane overlay approach) were performed as
previously described (McDowell et al., 2005). In brief,
cell lysates of each strain or recombinant protein
were solubilized and separated by sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–
PAGE). Equal loading of recombinant proteins and
protein integrity were assessed by staining with Coo-
massie blue. Proteins were transferred to polyvinylid-
ene ﬂuoride, overlaid with puriﬁed human FH
(10 lg ml1 in phoshphate-buffered saline with 0.2%
Tween-20 (PBST); Complement Tech, Tyler, TX) and
bound FH was detected using goat anti-FH antiserum
(1 : 800 dilution, Complement Tech). Horseradish
peroxidase-conjugated rabbit anti-goat immunoglobu-
Table 1 Oligonucleotide primers (50–30) used in this study1
TDE0107Up TTTATTCCACCATTCCATACATC
TDE0109Rev CGATATTCATGACGTTTACTAC
FhbB1 LIC (+) GACGACGACAAGATTACTTTCAAAATGAATACTGCAC
FhbB1 LIC () GAGGAGAAGCCCGGTTTACTTTATCTTTTTGGGTAT
FhbB2 LIC () GAGGAGAAGCCCGGTTTACTTTATCTTCTTGGGTACAAAGCG
FhbB3 LIC (+) GACGACGACAAGATTGCTTTTAAAATGAATACTGCAC
FhbB3 LIC () GAGGAGAAGCCCGGTTTACTTTTTCTTGGGTACAAAG
CCP1 LIC (+) GACGACGACAAGAAGGAAGATTGCAATGAACTTCCTCC
CCP4 LIC () GAGGAGAAGCCCGGTTCATGATTTTTCTTCACATGAAGGCCAC
CCP5 LIC (+) GACGACGACAAGAAATCATGTGATAATCCTTATATTC
CCP6 LIC (+) GACGACGACAAGAAACCTTGTGATTATCC
CCP7 LIC () GAGGAGAAGCCCGGTTCAGACACGGATGCATCTGGGAGTAG
CCP8 LIC (+) GACGACGACAAGAAAAAAACATGTTCCAAATCAAGTATAG
CCP13 LIC () GAGGAGAAGCCCGGTTCATGCCATTGAGCAGTTCACTTC
CCP14 LIC (+) GACGACGACAAGAAACAATTATGCCCACCTCCACCTC
CCP18 LIC () GAGGAGAAGCCCGGTTCAAGAATCTTTGCATTGAGGTGGTTC
CCP19 LIC (+) GACGACGACAAGATCAAAGATTCTACAGGAAAATGTG
CCP20LIC () GAGGAGAAGCCCGGTCTATCTTTTTGCACAAGTTGGATAC
1The segment of each primer that was included to allow for annealing with the pET46 Ek/LIC vector is indicated by underlining.
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lin G antibody served as the secondary antibody
(1 : 20,000 dilution, Calbiochem, San Diego, CA).
Treponema denticola strains 35405 and 35405fhbB
served as positive and negative controls for the
FH-binding assays, respectively.
Binding of full-length FH and CCP constructs to
r-FhbB proteins was assessed by enzyme-linked
immunosorbent assay (ELISA) as previously
described (Miller et al., 2013). Recombinant FhbB
proteins were immobilized overnight at 4°C in tripli-
cate wells of ELISA plates (1 lg per well in 100 mM
NaHCO3, pH 9.6). Borrelia hermsii FH-binding pro-
tein, FhbA, and bovine serum albumin were also
immobilized and served as positive and negative con-
trols, respectively. Non-speciﬁc binding was blocked
for 1 h with 5% non-fat dry milk in PBST. Puriﬁed full-
length human FH and r-CCP constructs (10 lg ml1
in PBST) were added to the wells for 1 h followed by
three washes with PBST. Goat anti-human FH
(1 : 800 in PBST + 5% milk; Complement Tech) was
added to each well for 1 h, followed by three washes
and application of rabbit anti-goat immunoglobulin G
conjugated to horseradish peroxidase (1 : 20,000 in
PBST + 5% milk) for 1 h. The plates were washed
three times with PBST and antibody binding was
detected using 2,20-azino-bis(3-ethylbenzothiazoline-
6-sulphonic acid; 405 nm). The data were normalized
to r-FhbB35405 and averaged across three plates.
To determine whether sucrose octasulfate (SOS)
can inhibit FH binding, plates were coated and non-
speciﬁc binding was blocked as described above. FH
(5 lg ml1) was incubated with increasing concentra-
tions of SOS (0–50 mM) in PBST for 1 h with constant
gentle agitation. The immobilized FhbB was overlaid
with the FH-SOS solution for 1 h. The wells were
washed three times with PBST and binding was
detected as described above. The data were normal-
ized to FH binding with no SOS added. The data pre-
sented are representative of three independent
experiments.
The kinetics of the FhbB–FH interaction was
assessed by surface plasmon resonance using a Bia-
core T200 and the data were evaluated using
BIAEVALUATION V1.1 (Biacore, Uppsala, Sweden)
(Miller et al., 2012, 2013). Brieﬂy, r-FhbB proteins
(ligand) were immobilized on nitrilotriacetic acid chips
(GE Healthcare, Chalfont St Giles, UK) via their N-ter-
minal His-tag and increasing concentrations of puri-
ﬁed human FH (analyte; Complement Tech) were
added in the ﬂuid phase. The kinetics data were ﬁtted
to a Langmuir 1 : 1 binding model and averaged from
three replicate experiments.
Measurement of dentilisin activity and FH
cleavage
The dentilisin activity of each strain was determined by
measuring its efﬁciency in hydrolysis of succinyl-L-ala-
nine-L-alanine-L-prolyl-L-phenylalanine-p-nitroanalide (SA-
APFNA; Sigma-Aldrich, St Louis, MO) (Uitto et al., 1988;
Miller et al., 2013). Aliquots of mid- to late-log phase cul-
tures were pelleted by centrifugation (5000 g, 15 min,
4°C), suspended in buffer A (100 mM NaCl, 1 mM CaCl2,
50 mM Tris–HCl, pH 8.0) and transferred to 96-well plates.
SAAPFNA (1 mM in buffer A) was added to each well to a
ﬁnal concentration of 500 lM and the absorbance was
measured at 405 nm every 5 min for 60 min. The data
presented are the average of the measurement of three
wells per biological replicate and are representative of
three replicate experiments. The data are presented as
the change in absorbance between the 0-min and 60-min
time-points. The dentilisin-mutant strain 35405-CCE (Bian
et al., 2005) served as a negative control. Statistical sig-
niﬁcance was assessed using Student’s t-test.
Treponema denticola strains were assessed for
their ability to degrade FH. In brief, 0.1 OD600 of
freshly harvested, mid-log phase cells were incubated
with 40 lg ml1 human FH (Complement Tech) in
PBS (50-ll reaction volume). A sample was immedi-
ately removed at 0 min and the remainder was incu-
bated for 120 min at 37°C. The samples were
fractionated by SDS–PAGE, transferred to polyvinylid-
ene ﬂuoride and screened with anti-human FH
antiserum (dilution of 1 : 1000; Complement Tech).
Antibody binding was detected using 2,20-azino-bis(3-
ethylbenzothiazoline-6-sulfonic acid) at 405 nm.
Serum sensitivity analysis
Resistance to complement-mediated killing was deter-
mined as described in previous studies (McDowell
et al., 2011; Miller et al., 2013) with minor modiﬁca-
tions. Cells from mid-log phase cultures were incu-
bated with 40% complement-preserved human serum
(NHS; Innovative Research, Novi, MI) in the appropri-
ate growth media (either new oral spirochete medium
or OMIZ-P4; 37°C; anaerobic conditions; 0–3 h). To
determine if potential serum-mediated killing was
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complement dependent, strains were also incubated
with 40% serum that had been incubated at 56°C for
30 min to inactivate complement (heat-inactivated
serum; HIS). The percentage of intact cells (e.g. %
survival) was determined by cell counts using dark
ﬁeld microscopy (average of 10 ﬁelds of view under
1000 9 magniﬁcation). The values presented repre-
sent the number of morphologically intact cells
divided by the total number of morphologically intact
and disrupted cells (intact cell/intact and disrupted
cells 9 100). Cells with multiple outer sheath blebs
were determined to be morphologically disrupted.
RESULTS
Complement resistance of oral treponemes
A BLAST search of determined oral treponeme gen-
ome sequences (Human Microbiome U54 initiative,
Broad Institute, Cambridge, MA; broadinstitute.org),
revealed that sequences with signiﬁcant primary
sequence homology to fhbB are found only in T. den-
ticola. To determine if other oral treponeme species
may bind FH via a protein that is unrelated to FhbB,
FH ALBI assays were performed (Fig. 1A). Of the
seven species tested, only T. denticola 35405 bound
human FH and binding occurred to an 11-kDa protein
consistent with the molecular mass of FhbB35405. As
expected, T. denticola 35405δfhbB did not bind FH.
To determine if the inability of some treponemal
species to bind FH correlates with serum sensitivity,
representative strains were incubated with 40% NHS
or HIS and percent survival was determined (Fig. 1B).
Less than 5% of T. amylovorum and T. vincentii cells
survived in the presence of NHS, whereas > 95% of
the cells survived in HIS. Based on these data, it can
be concluded that serum-mediated killing of these
species is complement-dependent. Treponema med-
ium, T. maltophilum, T. pectinovorum, and T. socran-
skii were resistant to 40% NHS with > 90% survival.
These results indicate that ﬁve of the seven oral
treponemes tested in this study are highly resistant to
complement-mediated killing. While FH binding is
essential to the survival of T. denticola, it does not
contribute to the serum resistance of several other
oral treponeme species.
Identiﬁcation and phylogenetic analysis of fhbB
variants
The fhbB sequences of T. denticola isolates 35405,
GM-1 and 33520 were previously determined and
found to be nearly identical (McDowell et al., 2007).
Recently, a divergent FhbB protein produced by iso-
late 33521 was identiﬁed and demonstrated to bind
FH (Miller et al., 2013). To conduct comprehensive
analyses of fhbB phylogenetics, sequences derived
from 43 isolates of T. denticola were aligned. Four
were previously determined, nine were from deter-
mined genomes sequences and 30 were determined
as part of this study. Phylogenetic analyses delin-
eated three FhbB phyletic clusters that are well
A B
Figure 1 Analysis of factor H (FH) binding to oral treponemes. (A) Cell lysates of seven oral treponeme species (as indicated above each
lane) were solubilized, fractionated by SDS–PAGE, and transferred to membranes. After blocking the membranes were overlaid with puriﬁed
human FH and FH binding detected as detailed in the text using anti-human FH antibody. To assess serum sensitivity, mid-log phase cultures
of each species were incubated in 40% NHS (B) or HIS (data not shown) for 0, 1 or 3 h under anaerobic conditions. Percent survival,
expressed as the number of morphologically intact cells divided by the total number of intact and morphologically disrupted cells 9 100, was
assessed using dark-ﬁeld microscropy as detailed in the text.
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supported by bootstrap analysis (Fig. 2). Twenty-one
of the sequences (48.8%) were type 1 FhbB (desig-
nated as FhbB1), 14 (32.6%) were type 2 (FhbB2)
and eight (18.6%) were type 3 (FhbB3). Throughout
the manuscript, the isolate of origin for each FhbB
sequence, where appropriate to specify, is indicated
by subscript (i.e. FhbB135405). Sequences within the
FhbB1 and FhbB2 clusters are highly conserved at
the intra-type level while FhbB3 sequences displayed
greater divergence. An alignment of representative
sequences is presented in Fig. 2. The structure of
FhbB135405 was previously determined at 1.7 A
Figure 2 Identiﬁcation of three major Treponema denticola FhbB phyletic clusters. The phylogenetic relationships among FhbB sequences
(n = 43) were assessed using the neighbor-joining method (top panel). The results of bootstrap analyses (500 bootstrap replicates) are indi-
cated at each node. The Borrelia hermsii FhbAYOR FH binding protein was used to root the tree. The middle panel presents an FhbB amino
acid alignment with FhbB135405 serving as the reference strain. Identical residues are shown as dots. Secondary structure elements as
inferred from the known atomic structure of FhbB135405 (Miller et al., 2011, 2012) are indicated above the alignment. Alpha helices 1–2 map
within the negatively charged face of FhbB that has been demonstrated to serve as the FH interaction domain. The bottom panel presents a
matrix of amino acid identity and similarity values (upper and lower quadrants, respectively).
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resolution (Miller et al., 2011, 2012). An amino acid
identity/similarity matrix is also presented in Fig. 2. All
sequences are predicted to encode lipoproteins with
a conserved 23 amino acid leader peptide that, after
processing, yields a ~11.4-kDa mature protein that is
tethered to the cell surface via its lipid moiety.
To assess potential structural conservation among
FhbB variants, representative FhbB1, FhbB2 and
FhbB3 sequences were threaded onto the FhbB135405
atomic structure. The models obtained were analysed
by MOLPROBITY to identify those with the fewest all-atom
clashes and the highest percentage of residues with
favored Ramanchandran phi-psi angles. All FhbB
variants analysed displayed a high conﬁdence-strong
structural ﬁt with the FhbB135405 structure. Only minor
structural variations were observed (Fig. 3A). Analyses
of surface charge distribution maps (overlaid on the
structures in Fig. 3) revealed that consistent with
FhbB135405, all FhbB variants have well deﬁned posi-
tively and negatively charged surfaces.
Using all known FhbB amino acid sequences, a
sequence conservation map was generated using
FhbB135405 as the reference structure (Fig. 3B). The
greatest degree of sequence diversity among variants
maps within residues 20 through 66 (middle of a helix
1 to the C-terminus of ahelix 2). It is this region of
FhbB1 that has been demonstrated to serve as the
FH interaction domain (McDowell et al., 2009; Miller
et al., 2011, 2013).
Mapping of the FH interaction site for FhbB1,
FhbB2 and FhbB3 proteins
Previous studies demonstrated that the FH-binding site
for FhbB135405 is within CCP 6–8 and overlaps with a
glycosaminoglycan (GAG) -binding site (Giannakis
et al., 2003; Miller et al., 2012). In this report, ELISAs
were used to investigate the binding of full-length puri-
ﬁed human FH and r-FH CCP constructs to each FhbB
type (Fig. 4A). All FhbB proteins bound full-length FH
A
B
Figure 3 Structural models, charge distribution maps and sequence conservation of FhbB variants. Comparative modeling of the three-dimen-
sional structures of each FhbB type (A) was performed using MODELLER (University of California San Francisco, San Francisco, CA) based
upon the known structure of FhbB135405 (PDB 3R15). The ribbon diagrams of FhbB (gray) were overlaid with color-coded, transparent electro-
static surface maps. Residues of negative and positive charge are shown in red and blue, respectively. Each structure was rotated through
180° to show both the front and back view of each model. (B) A conservation map using the FhbB135405. A conservation score was calculated
for each residue using the CONSURF algorithm. Conserved, variable and highly variable residues shown in gray, light green and dark green,
respectively. All methods are described in the text.
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and r-FH constructs consisting of CCP 6–8, CCP –7,
and CCP 6–7 but not to CCP 19–20. The FH- and
plasminogen-binding protein from Borrelia hermsii,
FhbA (Hovis et al., 2004; Rossmann et al., 2007),
which exclusively interacts with CCP 19–20 of FH (Ho-
vis et al., 2006), served as a binding speciﬁcity control.
Bovine serum albumin served as a negative control.
FhbB2 displayed the lowest level of binding to FH and
the CCP 6–7 domain. To further verify that the FhbB
variants bind within the GAG-binding site of CCP 6–7,
competitive binding analyses were conducted using
SOS, a synthetic GAG-analog (Fig. 4B) (Prosser et al.,
2007). SOS inhibited binding of FH binding to each
FhbB type in a dose-dependent manner.
Surface plasmon resonance approaches were
employed to compare the binding kinetics of the three
major FhbB types with FH (Fig. 4C). The KD value for
the FhbB2–FH interaction was similar to that reported
for Fhb1 and FhbB3 FH interactions (Miller et al.,
2012, 2013). In comparing the kinetics of the interac-
tion of each FhbB type with FH, the KD value for the
FhbB–FH interaction is largely a reﬂection of a slower
off rate. This could compensate for lower afﬁnity bind-
ing and allow for more efﬁcient cleavage of FH by
T. denticola strains producing FhbB2 proteins.
Serum resistance does not correlate with FhbB
type or proteolytic activity
To determine if dentilisin activity, and thus FH cleav-
age, correlates with levels of serum resistance, the
dentilisin activity of 16 T. denticola strains was
A
B
C
Figure 4 FhbB binding to speciﬁc complement control protein (CCP) domains of factor H (FH) and the inﬂuence of the glycosaminoglycan
analog, sucrose octasulfate (SOS), on the interaction. ELISA analyses were conducted to localize the binding site(s) of different FhbB variants
on FH (A). Recombinant (r-) FhbB variants, r-FhbA (a Borrelia hermsii FH-binding protein) and r-FH subfragments spanning CCP5–7, CCP6–
7, CCP6–8 and CCP19–20 were generated as N-terminal His-tag fusions. The r-FhbB proteins were immobilized in the wells (as indicated)
and then full-length FH or r-CCP constructs were added. Binding was detected using anti-human FH antiserum, secondary antibody and
absorbance. To determine if SOS, which binds to several sites on FH including CCP6–7, inhibits FH binding to different FhbB variants (as
indicated above), ELISA analyses were performed (B). ELISA plate wells were coated with each FhbB protein and then FH with increasing
concentrations of SOS were added as detailed in the text. After washing, binding was assessed as detailed above. Surface plasmon reso-
nance analyses were conducted to determine if the kinetics of the FH–FhbB interaction differs among FhbB phyletic types (C). The calculated
ka, kd and KD values are presented to the right. Note that the data for FhbB1 an FhbB3 were presented in an earlier study.
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determined using the SAAPFNA cleavage assay
(Fig. 5A). Dentilisin activity varied widely among
strains with some having no discernable activity
under the conditions tested. Hence, based on this
observation we speculated that strains will differ sig-
niﬁcantly in their ability to cleave FH. To test this, the
A
B
Figure 5 Quantiﬁcation of the dentilisin activity of Treponema denticola strains producing FhbB1, FhbB2, and FhbB3 proteins. (A) Results of
SAAPFNA assays. Mid-log phase cultures were incubated with SAAPFNA and absorbance was read at 0 and 60 min. The absorbance value
obtained at 0 min (background) was subtracted from the value obtained after 1 h and the average of three assays was plotted. (B) Results of
factor H (FH) cleavage assays are presented. Each strain (as indicated above the panel) was incubated with FH and aliquots of the superna-
tant were collected at time 0 and 120 min were fractionated by SDS–PAGE, the proteins were transferred to membranes and the blots were
screened with anti-human FH antiserum as detailed above. The absence of a band at 150 kDa is indicative of FH cleavage.* P < 0.01.
Table 2 Data summary
Isolate
FhbB
type Dentilisin activity
Factor H
cleavage
% Survival
(NHS)
% Survival
(HIS)
35405 1 1.59  0.01 + 78.3  3.6 97.6  1.5
MS25 1 1.46  0.04 + 92.6  3.3 98.0  1.1
33520 1 0.58  0.01 + 87.5  3.2 98.9  0.4
N17A1 1 1.13  0.02 + 92.8  4.5 99.6  0.3
GM-1 1 0.65  0.02 + 93.6  2.3 97.9  1.3
SP48 2 0.54  0.01 + 94.9  1.2 96.5  2.5
SP55 2 0.01  0.02  83.4  20.4 97.2  0.8
SP54 2 0.01  0.01  82.0  13.2 98.1  0.8
SP50 2 0.08  0.01  86.9  9.0 95.0  4.9
SP49 2 0.26  0.02 + 90.0  14.6 95.4  4.8
SP72 2 0.01  0.01  68.7  10.2 95.1  1.4
35404 3 0.09  0.01 + 88.4  5.7 98.2  0.3
SP64 3 0.69  0.01 + 82.6  3.3 99.0  0.2
33521 3 0.01  0.01  98.4  1.7 97.4  0.2
CF171 3 1.02  0.01 + 93.8  3.9 97.3  1.7
CF170 3 1.44  0.03 + 94.5  3.5 95.7  1.5
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FH cleavage ability of each strain was analysed. The
majority of strains that produced FhbB2 or FhbB3
proteins either lacked or were attenuated in their abil-
ity to cleave FH (Fig. 5B). This suggests that there
may be signiﬁcant differences in the potential of
strains expressing different FhbB types to cause local
dysregulation of complement activation.
To determine if production of a given FhbB type pro-
tein inﬂuences the ability to evade complement-medi-
ated killing, each strain was exposed to 40%
complement-preserved NHS. In this assay, differences
in FH cleavage activity would not be expected to inﬂu-
ence serum resistance as the concentration of FH is
high in serum. As a negative control for this assay, cells
were also exposed to HIS, which possesses no com-
plement activity. The data are presented in Table 2. All
T. denticola isolates were highly resistant to serum-
mediated killing regardless of the FhbB type they
produced or dentilisin activity level. The mean percent
survival was 89.0% for FhbB1-producing strains,
84.3% for FhbB2-producing strains, and 91.5% for
FhbB3-producing strains. These results indicate a
trend that mirrors the afﬁnity of each FhbB type for FH.
These results suggest that FhbB type does not signiﬁ-
cantly affect FH binding or inﬂuence serum survival.
DISCUSSION
The impact of periodontal disease is not conﬁned to
the oral cavity as it correlates with increased risk for
several systemic diseases (Lopez, 2008; Taylor &
Borgnakke, 2008; Kavoussi et al., 2009; Inaba &
Amano, 2010). Hence, a detailed understanding of
phenotypic variation, mechanisms of persistence and
serum resistance of oral treponemes is an essential
step forward in devising strategies to combat these
important pathogens and minimize their impact on
overall human health. For oral treponemes to survive
and thrive in periodontal pockets they must possess
the ability to evade complement-mediated destruction
as gingival crevicular ﬂuid possesses levels of com-
plement proteins similar to that of serum. This study
is the ﬁrst comprehensive assessment of the serum
sensitivity of oral treponemes associated with peri-
odontal disease and of T. denticola phenotypic differ-
ences relevant to FH binding, cleavage and dentilisin
activity.
It was previously demonstrated that T. denticola
strain 35405 evades serum-mediated killing by
binding FH via the FhbB protein (McDowell et al.,
2007, 2011). Paradoxically, T. denticola strain 35405
has been demonstrated to cleave FH that is bound to
its surface using the protease, dentilisin (McDowell
et al., 2009). Based on this, it was hypothesized that
FH cleavage will result in its local depletion triggering
dysregulation of complement activation and the down-
stream destructive processes that culminate in peri-
odontal disease. To better understand the role of FH
binding in survival of treponemes in the subgingival
environment, FH binding and serum sensitivity of
seven oral Treponema species were tested. In addi-
tion, we assessed variation in speciﬁc phenotypic
properties of T. denticola that are relevant to immune
evasion and the potential to cause immune dysregu-
lation. FH binding by representative strains of seven
oral treponeme species (T. denticola strain 35405,
T. socranskii, T. medium, T. pectinovorum, T. malto-
philum, T. vincentii and T. amylovorum) was tested
using ALBI assays. Among this panel of isolates only
T. denticola 35405 bound FH. FH-binding analyses of
15 additional T. denticola isolates revealed that this
phenotype is shared by 13 of 15 isolates (87%).
While FH bound only weakly to isolates CF170 and
CF171 using the ALBI assay approach, r-FhbB3 pro-
teins derived from these strains bound FH at a level
similar to other r-FhbB proteins and FhbB expression
was clearly detected using immunoblot analyses
(data not shown). Consistent with the inability of other
cultivable treponemal species to bind FH, a homolog
of FhbB was not detected in available genome
sequences. It can be concluded that among the major
cultivable oral treponemes, the FH-binding phenotype
is unique to T. denticola.
Some pathogens evade complement-mediated kill-
ing using non-FH-dependent mechanisms including
the binding of complement regulatory proteins C4BP
and vitronectin (Potempa et al., 2008; Barbosa et al.,
2009; Grosskinsky et al., 2010; Singh et al., 2010;
Schwab et al., 2013). To determine if serum-resistant
species that do not bind FH employ non-FH-depen-
dent complement evasion mechanisms, the serum
sensitivity of representative isolates of the seven spe-
cies listed above was assessed. Cells were exposed
to 40% NHS or 40% HIS for 3 h and cell survival was
measured. A serum concentration of 40% is consis-
tent with the estimated concentration of serum in gin-
gival crevicular ﬂuid (Schenkein & Genco, 1977a,b).
All isolates of T. denticola displayed signiﬁcant serum
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resistance and per cent survival in NHS ranging from
68 to 98%. Although T. socranskii, T. medium,
T. maltophilum and T. pectinovorum do not produce
FhbB or bind FH, more than 90% of the cells survived
after 3 h of exposure to NHS. In contrast, the
per cent survival of T. vincentii was 40% after 1 h,
dropping to less than 5% after 3 h. Treponema amy-
lovorum proved to be the most susceptible species
with complete killing occurring after 1 h exposure to
NHS. The role of complement in the killing process
was conﬁrmed using HIS. No killing was observed
with any isolate upon exposure to HIS. The data indi-
cate that T. socranskii, T. medium, T. maltophilum
and T. pectinovorum employ FhbB- and FH-indepen-
dent mechanisms to evade complement-mediated kill-
ing. To determine if serum-resistant species that do
not bind FH, bind C4BP and or vitronectin, ALBI
assays were performed using 20% human serum as
the source for C4BP and vitronectin. Speciﬁc binding
was not observed (data not shown). Future analyses
will focus on identifying the molecular basis of serum
resistance for T. socranskii, T. medium, T. maltophi-
lum and T. pectinovorum.
Prior to this study, the impact of fhbB sequence
variation on FH binding had been assessed in only
two isolates of T. denticola (35405 and 33521) (Miller
et al., 2013). In this study, phylogenetic relationships
among fhbB sequences obtained from 43 different
T. denticola isolates were assessed. Three distinct
phyletic clusters were delineated. The proteins
encoded by each cluster were designated as FhbB1,
FhbB2 and FhbB3. Sequences within the FhbB1 and
FhbB2 clusters were found to be highly conserved
with a signiﬁcantly greater degree of variation among
FhbB3 sequences. In spite of extensive sequence dif-
ferences, molecular modelling revealed that all FhbB
types possess the negatively charged surface region
previously shown to form the FH-binding domain of
FhbB135405 (Miller et al., 2012). However, the highest
degree of primary sequence divergence mapped
within the FH-binding interface. Recombinant FhbB
proteins representing each FhbB type were generated
and tested to determine if sequence variation inﬂu-
ences binding to FH or to speciﬁc CCP domains.
ELISA analyses with the r-FhbB proteins immobilized
in the wells revealed similar binding of each protein
to full-length FH. All FhbB variants bound to the
region of FH consisting of CCP domains 6 and 7, but
not to an FH fragment consisting of CCP19–20.
Hence, the FH interaction domain of diverse FhbB
proteins appears to be similar to that of FhbB135405
(Miller et al., 2012).
CCP6–7 have been demonstrated to be a contact
point for several bacterially produced FH-binding pro-
teins (reviewed in Zipfel et al., 2002, 2007; Zipfel &
Skerka, 2009). This region of FH is also a key inter-
action site for host-produced GAG (Giannakis et al.,
2001, 2003; Prosser et al., 2007). SOS, a GAG ana-
log, binds to multiple sites on FH including CCP7. To
further reﬁne the interaction site for FhbB variants on
FH, SOS competitive binding analyses were per-
formed. SOS inhibited binding of all variants to FH or
FH-derived fragments, providing further evidence that
all FhbB variants use similar contact points with
CCP7. Binding kinetics of the FH–FhbB interaction
were also assessed using surface plasmon reso-
nance. While the KD values for the FH interaction with
each FhbB type were similar, the on–off rates (ka and
kd) differed signiﬁcantly.
Treponema denticola strain 35405 has been dem-
onstrated to cleave FH in an FhbB-dentilisin-depen-
dent manner (McDowell et al., 2009). To date,
comparative analyses of dentilisin activity have been
limited to a few strains (Goetting-Minesky et al.,
2013) and a potential correlation between dentilisin
activity and FH cleavage in natural isolates has not
been assessed. In this study, the dentilisin activity of
16 T. denticola isolates was measured by monitoring
cleavage of the chromogenic substrate, SAAPFNA.
Activity varied widely among isolates with some dis-
playing no or minimal activity. This observation is
consistent with an earlier study that demonstrated sig-
niﬁcant differences of dentilisin activity among strains
(Goetting-Minesky et al., 2013). Four of the isolates
investigated in this study (35405, 33520, 35404 and
33521) were also analysed by Goetting-Minesky et al.
(2013). The results obtained in these two studies are
in excellent agreement; however, differences in the
methods of data analysis resulted in slight differences
in conclusions. In this study, we subtracted the absor-
bance obtained at time zero from the absorbance
measured at 2 h whereas Goetting-Minesky et al. did
not. Using this approach we conclude that isolates
35404 and 33521 are devoid of activity as opposed
to the conclusion that they possess low-level activity.
Dentilisin is considered to be a major virulence factor
for T. denticola (Ishihara et al., 1996, 1998; Ellen
et al., 2000; Chi et al., 2003; Miyamoto et al., 2006;
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Yamazaki et al., 2006; Bamford et al., 2007; McDo-
well et al., 2009). Variation in its activity among
strains could prove to be of considerable epidemio-
logical value and could inﬂuence disease progression.
It remains to be determined if strains that display
higher levels of dentilisin activity are more virulent.
The relative proportion of strains with high vs. low
activity within a speciﬁc anatomical site could poten-
tially be a contributing factor in disease severity. In
analyses of strain 35405, efﬁcient FH cleavage was
demonstrated to be directly dependent on FhbB and
dentilisin (McDowell et al., 2009). The ability of a
broad panel of T. denticola strains to directly cleave
FH, and the dependence of this activity on dentilisin,
were assessed. Dentilisin activity was found in all
FhbB1 strains tested, whereas FhbB2 and FhbB3
strains did not all yield measurable dentilisin activity.
Strains that produce FhbB1 proteins were found to
have signiﬁcantly greater FH cleavage ability than
strains that produce FhbB2 and FhbB3 proteins.
However, there were some exceptions as some
strains with low dentilisin activity were able to cleave
(SP55 and SP54) or partially cleave (35404) FH. It
can be concluded that while dentilisin is a key con-
tributor to FH cleavage, in some strains it is possible
that other proteases may also play a role.
In conclusion, this report demonstrates that the
serum-resistance phenotype ﬁrst described for
T. denticola is shared by several oral treponemes.
However, the molecular mechanisms responsible for
serum resistance differ among species. Treponema
denticola uses an FH-dependent mechanism while
other serum-resistant species employ a yet to be
deﬁned, FH-independent mechanism. All T. denticola
isolates tested, in spite of signiﬁcant FhbB sequence
variation within their FH interaction domain, bound
FH, but not all strains cleaved FH. The differences in
FH–FhbB binding kinetics observed for the three
FhbB phyletic types and the wide range in dentilisin
activity noted among T. denticola strains was striking
and suggests that in vivo the T. denticola population
is heterogeneous with regard to these key virulence-
related activities. It is our hypothesis that strains that
produce FhbB1 proteins and have higher dentilisin
activity will display greater virulence. Hence, the rela-
tive proportions of strains present in the subgingival
crevice that differ in these activities could signiﬁcantly
inﬂuence disease progression and severity. Studies
are currently underway to directly address these
questions. A human FH transgenic mouse model that
has been extensively used to study the role of FH
binding in the pathogenesis of Neisseria meningitidis
(Beernink et al., 2011; Vu et al., 2012) is now being
employed by our laboratory to determine if fhbB
genotype, FH binding, FH cleavage and dentilisin
activity inﬂuence alveolar bone loss during periodontal
disease.
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